FIGURE SUMMARY
Title

An inducible transgene expression system for zebrafish and chick

Authors
Gerety, S.S., Breau, M.A., Sasai, N., Xu, Q., Briscoe, J., and Wilkinson, D.G.
Source
Full text @ Development

Activity of ERT2-GAL4 in vivo is 4-OHT dependent, rapid and dose sensitive. (A-K) Stable transgenic fish lines expressing ERT2-GAL4 under control of the Xenopus EF1α promoter show robust transactivation of UAS-linked H2B-citrine (C,D), GFP-dnCasp9 (G,H) or Myc-hoxb8a (J,K) when treated overnight with 0.5 μM 4-OHT (all in green channels), compared with controls (A,B,E,F,I, green channel). In some samples, nuclei are labelled with DAPI (B,D,I-K, red channel) and/or brightfield (A-H, grey) to visualize the embryo. (L-V) A time-course of UAS-linked transgene transcription (in situ hybridisation for GFP, purple) driven by ERT2-GAL4 shows 4-OHT dependence (controls in N,Q,T versus 4-OHT treated in O,R,U and P,S,V). The kinetics and intensity of response are dose dependent: embryos treated with 5 μM 4-OHT show more rapid, stronger and less mosaic transcription from the UAS-driven transgene than 0.5 μM 4-OHT-treated embryos (compare P,S,V with O,R,U) over the 6-hour treatment course. Embryos treated overnight with 0.5 μM 4-OHT (control in L, 4-OHT in M) show robust GFP transcription. The light pigmentation around the eye of embryos at 6 hours in T is not in situ signal.

Tissue-specific ERT2-GAL4 produces 4-OHT-dependent, region restricted activity of transgene expression. (A-E) Transient transgenics in which ERT2-GAL4 is under control of the HuC enhancer/promoter show robust neuron-specific expression from co-injected UAS::H2B-citrine when embryos are treated overnight with 0.5 μM 4-OHT, compared with controls (compare B-E versus A, green channel). Staining with anti-HuC/D antibody reveals the endogenous expression pattern of this gene (A-E, red channel). Images in A-C are maximum projections of the entire embryo thickness (36-40 μm). Images in D,E are enlarged maximum projections of a 5.7 μm stack from embryo in C. (F-M) Stable transgenics in which cldnB enhancer/promoter drives ERT2-GAL4 show robust induction and 4-OHT dependence of a stable 5×UAS::H2B-citrine transgene (compare J,K,L versus F,G,H, green channel). When treated with 1 μM 4-OHT from 50% epiboly, embryos express Citrine in the migrating lateral line primordium and deposit neuromasts at 30 hpf (dotted ovals in K and J, respectively, green channel). Persistent expression of the UAS-linked citrine at 48 hpf in neuromasts is detected by in situ hybridisation for citrine transcript (compare M with I, red circled purple signal). Some samples were co-stained with DAPI to reveal nuclei (F-H,J-L, red channel). Additional Citrine-positive cells outside the lateral line structures in J-L reflect the expression of Cldnb in the skin.

ERT2-GAL4 under the control of the ubiquitin promoter can drive widespread, 4-OHT-dependent activity to 24 hours post-fertilisation. (A-K) Stable ubi::ERT2-GAL4 lines were crossed to a UAS::H2B-citrine line, and embryos were treated overnight with ethanol (A,D,G) or 0.75 μM 4-OHT (B,C,E,F,H-K) from 50% epiboly to 21 hpf. Confocal analysis of single optical planes reveals near-ubiquitous GAL4 activity in a 4-OHT-dependent manner in one line (A,D,G versus B,C,E,F,H,I, Citrine in green channel, DAPI in red channel). Arrowheads indicate Citrine-negative cells. A second independent ubi::ERT2-GAL4 line showed much weaker and more mosaic expression (J,K versus H,I, Citrine in green channel, DAPI in red channel), suggesting insertion site-dependent effects on ubiquitin promoter activity. Representative Citrine-negative cells in E,H are indicated by arrowheads. (L) Upon withdrawal of 4-OHT from Citrine-positive embryos from 18 hpf to 42 hpf (24 hour withdrawal, washouts A, B and C), mRNA levels of citrine drop by 67-85% compared with embryos maintained in 4-OHT (+4-OHT) (n=3 clutches) (compare +4-OHT with washouts A, B and C). qPCR levels are relative to embryos maintained in 4-OHT. Error bars indicate ±s.e.m. (overall signficant difference between +4-OHT and washout conditions, t-test, P<0.002).

ERT2-GAL4-driven expression is sufficient to generate gain-of-function phenotypes in vivo. (A-O) Embryos from a Ubiquitin::ERT2-GAL4 fish crossed to UAS::GFP-dnCasp9 fish were treated with ethanol (A,B,F,G,K,L) or 0.625 μM 4-OHT (C-E,H-J,M-O) from 50% epiboly to 18 hpf, followed by added treatment with 10 μM HA14-1 for 2 hours. Staining for activated caspase 3 (red channel) and GFP (green channel) reveals a rescue of HA14-1-induced apoptosis by widespread GAL4-induced expression of dominant-negative caspase 9 (compare K,L with M,N, red channel) in embryonic trunk. In embryos with mosaic GAL4 activity (E,J,O, GFP in green channel), the rescue of apoptosis is cell-autonomous to the GFP-dnCasp9-expressing cells (E,J,O, compare non-overlapping green and red). Samples were co-stained with DAPI (A-E, blue channel) to reveal nuclei of all cells. All images are side views of the trunk at 20 hpf.

Transient ERT2-GAL4 expression under the control of the ubiquitin promoter drives widespread, 4-OHT dependent activity. One-cell stage embryos were co-injected with the Ubiquitin::ERT2-GAL4 and UAS::H2B-citrine plasmids, and were treated overnight with ethanol (control, A,B,E,F) or 0.75 μM 4-OHT (C,D,G,H) from 50% epiboly to 21 hpf. Embryo-wide GAL4 activity is revealed by the expression of Citrine in a 4-OHT-dependent manner (Citrine in green channel, dark field in grey channel). The non-uniform pattern of Citrine expression reflects the mosaic inheritance of plasmid DNA in transient transgenics. A small number of Citrine-positive cells are seen in untreated embryos (A,B,E,F), but not in stable transgenics bearing the same constructs (see Fig. 4). E-H are higher magnicifcation images from embryos in A-D, respectively.

Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Development